Breaking News

Steriline Showcases New Robotic Nest Filling Machine

Features of the RayDyLyo closure system are designed to be more suitable to produce small and medium volumes in R&D labs or pilot lines.

By: Kristin Brooks

Managing Editor, Contract Pharma

Steriline, an Italian aseptic processing manufacturer, showcased its new Robotic Nest Filling Machine (originally intended for syringe-filling only), at CPhI Worldwide 2021 in Milan. The new machine works with the RayDyLyo solution, the all-in-one closure system developed by ARaymondLife which integrates a plastic push-fit cap as an innovative alternative to aluminium caps, and the SG EZ-fill vials in nest by Stevanato Group.
 

The features of the RayDyLyo closure system are designed to be more suitable to produce small and medium volumes in R&D labs or pilot lines, and Steriline chose to develop a solution working with RTU (ready-to-use) containers. Customers generally request flexible and high-speed equipment for R&D processes, and this solution features a simple and fast changeover that could be executed in a reasonable timeframe, according to the company.
 
“The development of the machine itself was not too complex since our stoppering and capping system could be very easily adapted to the RayDyLyo system,” says Giovanni Panzeri, Area Sales Manager MEA at Steriline. “Of course, the cap feeding system and stopper / cap pick-and-place unit must be adjusted to the physical characteristics (such as dimensions and weight) of the new caps, which means this must be considered in the design of the equipment.”
 
“The pre-sterilized SG EZ-fill vials provide a superior level of quality, compliance and patient safety.” states Fabio Bertacchini, Product Management Director at Stevanato Group “Available in Nest&Tub or tray configuration to accommodate different customers’ needs, they are an ideal solution both for clinical batches and commercial production. SG-EZ fill vials seek to maximize filling efficiency, preserve the glass mechanical resistance and reduce particle generation, streamlining production operations.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters